Experiment 492814

Worktypes

PHARMACOLOGY OF COMPOUND - IN VITRO

Compounds isolated

CALANOLIDE A

Details

PropertyValue
Pharmacology
REVERSE TRANSCRIPTASE INHIBITION
OrganismEmpty organism
CitationHIZI,A: TAL,R: SHAHARABANY,M: CURRENS,MJ: BOYD,MR: HUGHES,SH: MC MAHON,JB:. (1993). SPECIFIC INHIBITION OF THE REVERSE TRANSCRIPTASE OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND THE CHIMERIC ENZYMES OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 AND TYPE 2 BY NONNUCLEOSIDE INHIBITORS.. 37(5)
Amount utilized
Compound isolated
Dose amount300.0 MICROMOLS
Number2
Qualitative resultINACTIVE
Dose expressionIC50